Program Overview

The 2nd Annual Jefferson Lung Cancer Symposium is specifically designed for specialists whose practice focuses on the screening, diagnosis, management, and treatment of lung cancer utilizing a multi-disciplinary approach.


Lung cancer is ranked as the leading cause of cancer-related mortality both in the US and worldwide.  However, there have been dramatic advances in our understanding of the benefits of careful screening of high-risk individuals, the molecular biology of lung cancer, novel targets of importance, and the development of targeted therapies.  The Course Director, Dr. Mani S. Kavuru, MD, Professor of Medicine and the Director of the Division of Pulmonary and Critical Care Medicine, has developed a multidisciplinary program, offering participants a unique opportunity to witness experts in the fields of Pulmonary and Critical Care Medicine, Surgery, and Oncology as they review the most current literature supporting how they manage and treat patients diagnosed with this disease. 


Participants will examine case presentations from multiple perspectives, and gain in-depth understanding to how experienced healthcare providers approach difficult patient care decisions.  This active learning format features critical deliberations regarding the state of current knowledge, clinical findings, differential diagnoses and management plan options.  The program will also emphasize updated approaches to the diagnosis and treatment of lung cancer and will reinforce best practices through lively interactive case-based presentations, providing the opportunity for in-depth discussions on how the information presented at the conference can impact participant competency and their patient care processes, and allowing for a significant opportunity for audience members to interact with program faculty and discussants.  The didactic presentations will allow participants to observe and question faculty practitioners as they absorb the latest trends in practice, and demonstrate how to apply new information and evidence based guidelines into their own practices.


The goal of this continuing professional development activity is to support participant change through the demonstration of evidence-based discussion and practice pearls that will lead to changes in patient care and improved patient outcomes.  The activity will feature topics that are of interest to the multiple health care providers who are involved in care of patients with lung cancer.  Continuing education credits will be offered for physicians (AMA PRA Category 1 Credit™) and Respiratory Therapists (AARC credit).